跳至主要内容
临床试验/ISRCTN66395033
ISRCTN66395033已完成不适用

The effect of treating patients with anaemia in diabetic nephropathy to different target haemoglobin levels with epoetin beta

Barts and the London NHS Trust (UK)0 个研究点目标入组 160 人开始时间: 2006年12月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Male and female patients with diabetic nephropathy and chronic kidney disease III and IV
  • 2. Age more than 18 years and less than 80 years
  • 3. Haemoglobin less than 11.5 g/dl

排除标准

  • 1. Current treatment with an erythropoiesis-stimulating agent (ESA)
  • 2. Uncontrolled hypertension
  • 3. Congestive cardiac failure
  • 4. History of seizures
  • 5. History of thrombotic episodes
  • 6. Pregnancy
  • 7. Lactation
  • 8. Presence of systemic disease, infection or inflammatory conditions
  • 9. Hepatic insufficiency
  • 10. Active hepatitis
  • 11. Uncontrolled hypothyroidism
  • 12. Chronic alcoholism
  • 13. Known hypersensitivity to the active substance in the cartridge or benzoic acid
  • 14. Known sensitivity to epoetin beta

研究者

发起方
Barts and the London NHS Trust (UK)

相似试验